Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€22.04

€22.04

0.090%
-
0.090%
-
 
03.06.25 / Tradegate WKN: A28890 / Name: CompuGroup / Stock / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...

CompuGroup Medical SE & Co. KGaA Stock

There is nearly no change for the CompuGroup Medical SE & Co. KGaA stock today. Compared to yesterday it only changed by €0.000.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for CompuGroup Medical SE & Co. KGaA stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of CompuGroup Medical SE & Co. KGaA in the next few years

Pros
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

Analyzing the financials of CompuGroup, a company symbolized in the U.S. market, reveals a mixed yet intriguing picture of its operational efficiency, profitability, and overall market position. The financial statements indicate a company that has been navigating the complexities of its industry while showing resilience through fluctuations in revenue and net income. The company's metrics suggest potential growth, though they are tempered by some concerning trends in revenue growth and margins.

Strong Gross Profit Margins: The gross profit of approximately €1 billion showcases the company's ability to maintain a healthy margin despite operating in a competitive market. This capability not only reflects effective cost management but also places CompuGroup in a favorable position to invest in future opportunities.

Positive Earnings per Share (EPS): The reported EPS of €0.95, alongside a projected EPS of €1.77 for the current year, indicates that the company is not only generating profit but is expected to continue this trend. A robust EPS provides a firm foundation for attracting investors, as it demonstrates the company’s profitability on a per-share basis.

Comments

Buy CompuGroup Medical SE & Co. KGaA
Show more

Buy CompuGroup Medical SE & Co. KGaA
Show more

Buy CompuGroup Medical SE & Co. KGaA
Show more

News

EQS-News: CompuGroup Medical and CVC plan delisting – public delisting offer announced by CVC
EQS-News: CompuGroup Medical and CVC plan delisting – public delisting offer announced by CVC
EQS-News: CompuGroup Medical and CVC plan delisting – public delisting offer announced by CVC
EQS-News: Q1/2025: CompuGroup Medical reports slow start into the year
EQS-News: Q1/2025: CompuGroup Medical reports slow start into the year
EQS-News: Q1/2025: CompuGroup Medical reports slow start into the year
EQS-News: Final regulatory approval for voluntary public takeover offer – Strategic partnership between CVC and CompuGroup Medical takes effect upon completion of the offer
EQS-News: Final regulatory approval for voluntary public takeover offer – Strategic partnership between CVC and CompuGroup Medical takes effect upon completion of the offer
EQS-News: Final regulatory approval for voluntary public takeover offer – Strategic partnership between CVC and CompuGroup Medical takes effect upon completion of the offer